KAIROS

Thesis

Kairos Ventures is a venture capital firm founded in 2015, focusing on investing in groundbreaking ideas, patents, and businesses originating from top universities and scientists. Their primary sectors of interest are Life Sciences and Physical Sciences, with a strong emphasis on commercializing scientific discoveries into viable businesses. The firm targets companies with the potential to create a significant global impact, particularly those in the Global South with a leading focus on India. Kairos Ventures prefers to invest at the Seed to Series A stages, looking for tech and AI-enabled, for-profit enterprises that address large-scale challenges. Key investment criteria include defensible distribution, strong unit economics, and measurable outcomes. The typical investment check size ranges from $250K to $1M, although larger deals between $10M-$50M are also considered. Their investment strategy is geared towards building world-changing businesses from scientific innovation, with a particular interest in emerging markets and disruptive technologies. The firm's operational model involves building ventures and transforming high-potential companies into investment-grade assets before significant institutional capital is deployed, often presenting companies with Series A maturity at a seed-plus price point. They also have a focus on de-risked venture investments in Africa, emphasizing execution as a key asset class and embedding a strong operational team with experienced executives. The firm's associated entities, such as Kairos HQ, also engage in company building and venture capital, focusing on consumer brands and early-stage investments. Kair

Related lists

• Seed-stage AI investors
• Series A AI investors